Total Payments
$5,866
2024 Payments
$67.72
Companies
6
Transactions
15
Medicare Patients
3,517
Medicare Billing
$659,145
Payment Breakdown by Category
Consulting$2,900 (49.4%)
Other$2,000 (34.1%)
Food & Beverage$913.68 (15.6%)
Travel$52.19 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,900 | 1 | 49.4% |
| Honoraria | $2,000 | 1 | 34.1% |
| Food and Beverage | $913.68 | 11 | 15.6% |
| Travel and Lodging | $52.19 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,169 | 4 | $0 (2019) |
| Novocure Inc. | $2,238 | 5 | $0 (2018) |
| Boston Scientific Corporation | $145.05 | 1 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $126.71 | 2 | $0 (2023) |
| Siemens Medical Solutions USA, Inc. | $119.77 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $67.72 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.72 | 2 | Novartis Pharmaceuticals Corporation ($67.72) |
| 2023 | $233.95 | 2 | Siemens Medical Solutions USA, Inc. ($119.77) |
| 2019 | $3,314 | 5 | AstraZeneca Pharmaceuticals LP ($3,169) |
| 2018 | $162.06 | 2 | Novocure Inc. ($149.53) |
| 2017 | $2,088 | 4 | Novocure Inc. ($2,088) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $34.61 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $33.11 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Siemens Medical Solutions USA, Inc. | Varian Ethos Treatment Planning (Device) | Food and Beverage | In-kind items and services | $119.77 | General |
| Category: Oncology | ||||||
| 10/07/2023 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $114.18 | General |
| Category: Oncology | ||||||
| 09/23/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $2,900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $125.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Travel and Lodging | In-kind items and services | $31.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/29/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $111.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2019 | Boston Scientific Corporation | GENERAL ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $145.05 | General |
| Category: GENERAL | ||||||
| 11/29/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $149.53 | General |
| Category: Optune | ||||||
| 10/26/2018 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Oncology | ||||||
| 04/01/2017 | Novocure Inc. | Optune (Device) | Honoraria | Cash or cash equivalent | $2,000.00 | General |
| Category: Oncology | ||||||
| 04/01/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $49.99 | General |
| Category: Oncology | ||||||
| 04/01/2017 | Novocure Inc. | Optune (Device) | Travel and Lodging | Cash or cash equivalent | $20.87 | General |
| Category: Oncology | ||||||
| 04/01/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 853 | 2,578 | $717,821 | $154,820 |
| 2022 | 18 | 946 | 2,976 | $782,704 | $172,903 |
| 2021 | 19 | 948 | 2,956 | $798,507 | $175,320 |
| 2020 | 17 | 770 | 2,610 | $697,276 | $156,103 |
Total Patients
3,517
Total Services
11,120
Medicare Billing
$659,145
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 78 | 265 | $189,740 | $40,360 | 21.3% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 69 | 1,155 | $75,075 | $18,889 | 25.2% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 48 | 53 | $91,743 | $17,831 | 19.4% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 84 | 92 | $62,468 | $12,517 | 20.0% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 83 | 225 | $60,300 | $10,776 | 17.9% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 48 | 59 | $41,182 | $10,646 | 25.9% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 77 | 312 | $41,808 | $8,290 | 19.8% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Facility | 2023 | 13 | 14 | $28,042 | $7,272 | 25.9% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 30 | 33 | $32,637 | $5,955 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 74 | 87 | $14,007 | $4,594 | 32.8% |
| 77470 | Special radiation treatment | Facility | 2023 | 46 | 53 | $23,956 | $4,541 | 19.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 59 | 59 | $14,632 | $3,832 | 26.2% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 38 | 57 | $19,209 | $3,632 | 18.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 14 | 14 | $5,852 | $1,506 | 25.7% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 39 | 45 | $6,840 | $1,376 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $3,250 | $1,017 | 31.3% |
| 77293 | Obtaining respiratory data needed to develop the optimal radiation treatment | Facility | 2023 | 12 | 12 | $4,140 | $1,008 | 24.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 29 | 30 | $2,940 | $776.94 | 26.4% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 89 | 311 | $222,676 | $49,852 | 22.4% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2022 | 80 | 1,362 | $88,530 | $22,810 | 25.8% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 50 | 55 | $95,205 | $19,365 | 20.3% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 91 | 99 | $67,221 | $13,940 | 20.7% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 96 | 266 | $71,288 | $13,145 | 18.4% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2022 | 51 | 65 | $45,370 | $12,336 | 27.2% |
| 77300 | Calculation of radiation therapy dose | Facility | 2022 | 93 | 360 | $48,240 | $9,734 | 20.2% |
About Dr. Andy Su, MD
Dr. Andy Su, MD is a Radiation Oncology healthcare provider based in Elmhurst, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699897306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andy Su, MD has received a total of $5,866 in payments from pharmaceutical and medical device companies, with $67.72 received in 2024. These payments were reported across 15 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($2,900).
As a Medicare-enrolled provider, Su has provided services to 3,517 Medicare beneficiaries, totaling 11,120 services with total Medicare billing of $659,145. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Elmhurst, IL
- Active Since 04/04/2007
- Last Updated 08/22/2022
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1699897306
Products in Payments
- IMFINZI (Drug) $3,169
- Optune (Device) $2,088
- Oncology (Device) $149.53
- GENERAL ONCOLOGY (Device) $145.05
- Xofigo (Drug) $126.71
- Varian Ethos Treatment Planning (Device) $119.77
- LUTATHERA (Drug) $34.61
- PLUVICTO (Drug) $33.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.